XCELLEREX, INC.

Profile

Company Names

XCELLEREX, INC.

Addresses

170 LOCKE DRIVE, MARLBOROUGH, MA 01752

Phone Numbers

5084809235

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$1,956,502.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-01-28 
$1,956,502.00 
$5,400,000.00 
$3,443,498.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GUY 
 
BROADBENT 
EXECUTIVE OFFICER, DIRECTOR
XCELLEREX, INC.   |  SAMPLE6, INC.   |  THRIVE BIOSCIENCE, INC.   |  RADICAL PLASTICS, INC.
SCOT 
 
GALLIHER 
DIRECTOR
XCELLEREX, INC.
JON 
 
LIEBER 
EXECUTIVE OFFICER
XCELLEREX, INC.   |  CHECKMATE PHARMACEUTICALS, INC.
BORIS 
 
LIPKIN 
DIRECTOR
XCELLEREX, INC.
THOMAS 
 
MONATH 
DIRECTOR
XCELLEREX, INC.   |  VAXINNATE CORP   |  US BIOLOGIC, INC.
DOUGLAS 
 
TRECO 
DIRECTOR
XCELLEREX, INC.   |  INOZYME PHARMA, INC.   |  LITTLE SPARROWS TECHNOLOGIES, INC.
DAVID 
J. 
WILLIAMS 
DIRECTOR
XCELLEREX, INC.   |  SOLUTIONS BIOMED LLC   |  TTGA SBIC PIONEER FEEDER FUND, LP   |  TTGA SBIC PIONEER FUND I, LP
JOSEPH 
 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ZELOS THERAPEUTICS INC   |  XCELLEREX, INC.   |  AZELON PHARMACEUTICALS, INC.   |  THRASOS INNOVATION INC.   |  HAPTEN SCIENCES, INC.   |  SITEONE THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-02-04
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2011-01-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#